Bioqual, Inc. (BIOQ)

Market Cap	34.44M
Revenue (ttm)	46.54M
Net Income (ttm)	453.26K
Shares Out	894.42K
EPS (ttm)	0.51
PE Ratio	75.97
Forward PE	n/a
Dividend	0.50 (1.30%)
Ex-Dividend Date	Oct 7, 2024

Volume	208
Average Volume	747
Open	38.50
Previous Close	38.51
Day's Range	38.50 - 38.50
52-Week Range	33.00 - 66.00
Beta	-0.08
RSI	22.79
Earnings Date	Jan 21, 2026

About Bioqual

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides contract research services in the areas of AIDS, influenza, respiratory syncytial virus, Coronavirus, malaria, hepatitis, cancer, and other infectious diseases, as well as flavivirus infections, including zika and dengue. It also offers small and large animal models. In addition, the company provides cell-based assays, immunoassay, toxicology and cytotoxicity testing, viral load testing, and ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1981
• Employees: 113
• Stock Exchange: OTCMKTS
• Ticker Symbol: BIOQ